- Home
- RRGB vs INMB Comparison
RRGB vs INMB Comparison
Compare RRGB & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RRGB
- INMB
- Stock Information
- Founded
- RRGB 1969
- INMB 2015
- Country
- RRGB United States
- INMB United States
- Employees
- RRGB N/A
- INMB N/A
- Industry
- RRGB Restaurants
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- RRGB Consumer Discretionary
- INMB Health Care
- Exchange
- RRGB Nasdaq
- INMB Nasdaq
- Market Cap
- RRGB 91.6M
- INMB 103.1M
- IPO Year
- RRGB 2002
- INMB 2019
- Fundamental
- Price
- RRGB $5.56
- INMB $6.45
- Analyst Decision
- RRGB Strong Buy
- INMB Strong Buy
- Analyst Count
- RRGB 3
- INMB 2
- Target Price
- RRGB $12.50
- INMB $21.00
- AVG Volume (30 Days)
- RRGB 277.1K
- INMB 377.7K
- Earning Date
- RRGB 02-26-2025
- INMB 10-31-2024
- Dividend Yield
- RRGB N/A
- INMB N/A
- EPS Growth
- RRGB N/A
- INMB N/A
- EPS
- RRGB N/A
- INMB N/A
- Revenue
- RRGB $1,272,359,000.00
- INMB $42,000.00
- Revenue This Year
- RRGB N/A
- INMB N/A
- Revenue Next Year
- RRGB $0.95
- INMB N/A
- P/E Ratio
- RRGB N/A
- INMB N/A
- Revenue Growth
- RRGB N/A
- INMB N/A
- 52 Week Low
- RRGB $2.97
- INMB $4.32
- 52 Week High
- RRGB $11.25
- INMB $14.74
- Technical
- Relative Strength Index (RSI)
- RRGB 52.18
- INMB 63.48
- Support Level
- RRGB $5.31
- INMB $5.82
- Resistance Level
- RRGB $5.99
- INMB $6.83
- Average True Range (ATR)
- RRGB 0.38
- INMB 0.55
- MACD
- RRGB 0.00
- INMB 0.18
- Stochastic Oscillator
- RRGB 38.79
- INMB 83.61
About RRGB Red Robin Gourmet Burgers Inc.
Red Robin Gourmet Burgers Inc is a restaurant operator. The company develops, operates, and franchises casual-dining restaurants and fast-casual restaurants in North America. Its brands are Red Robin, Red Robin Gourmet Burgers, Red Robin America's Gourmet Burgers and Spirits, Red Robin Burger Works, YUMMM, Red Robin Gourmet Burgers and Brews, and Red Robin Royalty names and logos. The company's revenue consists of sales from restaurant operations, gift card breakage, franchise royalties and fees, and other miscellaneous revenue.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.